Peritoneal macrophages from mice infected with herpes simplex virus type 2 (HSV-2) exhibited extrinsic antiviral resistance. When the macrophages were cocultivated in vitro with virus-infected cells the yield of virus was reduced markedly. Activity was not present I to 2 days p.i., peaked at 3 to 4 days, declined by 7 days and was absent at 14 days after HSV-2 infection. The extrinsic antiviral activity was limited to the adherent peritoneal macrophage population. The macrophage antiviral activity was also dose-dependent, with approx, lO 8 macrophages (macrophage:host cell ratio of approx. 2:1) reducing virus plaques by > 9o % and virus yield 1.5 to 3.o loglo. Comparable extrinsic antiviral activity was also exhibited by Corynebacterium parvum-or thioglycollate-elicited peritoneal macrophages. The macrophage activity was not species-specific, activity on Vero cells or syngeneic mouse embryo fibroblasts being comparable. Activity was also not virus-specific, as the active macrophages also inhibited vesicular stomatitis virus (VSV). The antiviral effects required viable macrophages; cell lysates did not inhibit virus growth.
INTRODUCTION
Macrophages are important effector cells in host responses to virus infections (Mims, 1964; Allison, 1974; Silverstein, I975) . In mice inoculated with herpes simplex virus (HSV), mononuclear infiltrates are observed early around foci of herpetic infection (Johnson, 1964; Hirsch et al. 197o; Zisman et al. 197o ) and may be the first cellular response. Further evidence for the importance of macrophages in HSV infection comes from reports that agents which inhibit macrophages decrease resistance to HSV (Zisman et al. 197o; MeGeorge & Morahan, I978) , while macrophage-stimulating agents increase resistance (Morahan et al. I977c; Kirchner et aL I978) . Macrophages therefore appear to play a critical role in resistance to HSV, but how macrophages function in this capacity is largely unknown.
Resistance to virus replication within macrophages ('intrinsic resistance') has been described (Johnson, 1964; Stevens & Cook, I97I; Selgrade & Osborn, 1974; Mires & Gould, I978) . Macrophage antiviral effects on other virus-infected cells, 'extrinsic antiviral activity', has also been recently described (Morahan et al. 1977 b) . Both of these macrophage activities may be important in natural infection. Little information is available, however, concerning the temporal relationships between macrophage-mediated resistance mechanisms and antiviral immunity developing during virus infection. The presence of mononuclear infiltrates around early herpetic foci suggests that macrophages may exert activity early in infection.
oo22-13t7/8o/oooo-3799 $02.00© I980 SGM The present investigation was designed to establish directly whether macrophage extrinsic antiviral resistance developed during HSV infection. Our results indicate that activated macrophages appear early during HSV infection in mice and that these macrophages exhibit extrinsic resistance that is not virus-or species-specific.
METHODS
Mice. BALB/c age-and sex-matched (generally male) mice, 8 to IO weeks old, were used in all experiments. Mice were obtained from Laboratory Supply Co., Indianapolis, Ind., U.S.A. or Simonsen Laboratories, Gilroy, Calif., U.S.A. and weighed approx. 2o to 25 g. All animals were acclimatized for at least one week before use.
Peritoneal exudate cell preparations. Peritoneal cells (PEC) were prepared as described by Morahan et al. (I977b) . Briefly, mice were sacrificed and the peritoneal cavity of each animal was washed with Io ml of cold sterile Hanks' balanced salt solution (HBSS) without serum, containing 2 i.u. preservative-free heparin (Fellows Medical Manufacturing Co., Oak Park, Mich., U.S.A.) and 5o #g gentamicin (Schering, Kenilworth, N.J., U.S.A.) per ml. The pooled fluids were collected in 50 ml polypropylene tubes and centrifuged at 5oog for io min at 4 ° C to pellet the cells which were then washed three times with HBSS. The washed cells were counted and resuspended in Eagle's minimum essential medium with Earle's salts (MEM) containing 2% heat-inactivated foetal calf serum (FCS), 2 mMglutamine and 50/zg gentamicin/ml. PEC preparations were routinely stained for the monocyte non-specific esterase by the method of Tucker et al. (I977) and selected preparations were also tested by differential counts on Wright's stained smears or by acridine orange fluorescence. Differential counts and acridine orange fluorescence correlated well with esterase results. On the differential counts most of the non-monocytic cells were lymphocytes, with less than 2 0/0 polymorphonuclear neutrophils and basophils.
Macrophage activation. 'Activated' macrophages were obtained from mice inoculated intraperitoneally (i.p.) with Corynebacterium parvum killed vaccine (the kind gift of Dr John Whisnant, BurroughsWellcome Company, Research Triangle Park, North Carolina, U.S.A.) at a dose of 70 mg/kg 5 to 7 days prior to harvesting PEC. Macrophages were also elicited by i.p. injection of freshly prepared sterile Io% Brewer's thioglycollate (Difco, Detroit, Mich., U.S.A.), 0"5 ml per animal, 5 days before PEC collection. Normal resident macrophages were those obtained from uninoculated mice or mice inoculated with 0.2 ml of virus diluent.
Virus preparation and assay. Herpes simplex virus type 2 (HSV-2) was a stock maintained at a low passage in this laboratory (Morahan et al. I977a) . Pools of virus stock were prepared in HEp-2 cells and stored at -70 °C. Mice were inoculated i.p. with 7 x io 4 p.f.u. in 0.2 ml of virus diluent, which was sufficient to kill 60 to 80 0/0 of the mortality controls inoculated concurrently. HSV-elicited macrophages were obtained from HSV-2-infected mice on the specified day p.i. (unless otherwise stated, day 3). Vesicular stomatitis virus (VSV), Indiana strain, was prepared as described previously by Morahan & Grossberg (I 970) .
For all virus titrations, serial dilutions were prepared in cold GLB virus diluent (HBSS containing o.5~o gelatin and 0"25% Earle's lactalbumin hydrolysate). Assays for virus p.f.u, were performed on Vero cell monolayers in I6 mm tissue culture plates containing 24 wells. Virus dilutions (o.I ml/well) were allowed to adsorb for I h at 37 °C and then each well was overlaid with I ml of MC-MEM (MEM containing glutamine, antibiotics and 2 0/0 FCS, with I ~o methylcellulose, 4000 cP). After 3 days of incubation at 37 °C in 5 0/0 CO~. in air the plates were fixed with 4% aqueous formaldehyde, stained with 0.5% crystal violet and the virus plaques counted.
Assay of antiviral and antitumour activity. Vero cells or secondary syngeneic mouse embryo fibroblasts (MEF) were grown to confluency in 24-well plates. At confluency, each well contained about 5 x io 5 cells. Approx. 25 to 5o p.f.u, of HSV-2 was added to each well and the virus allowed to adsorb for I h at 37 °C. The cell monolayers were then washed three times with HBSS to remove unadsorbed virus and the PEC were added. The plates were incubated again for 2 h, at which time the non-adherent cells were removed by three washes with HBSS. One plate received MEM (containing 2 % heat-inactivated foetal calf serum and 50 #g gentamicin/ml), while a duplicate plate received MC-MEM for direct determination of virus plaques. The plates were incubated for I to 3 days at 37 °C. At that time, supernatant fluids were collected and stored at -70 °C for later determination of virus yield. The duplicate plate was fixed and stained at 3 days for HSV plaques. For each group of PEC used, I to 2 uninfected wells on each plate received PEC at the greatest concentration used in the experiment (generally 3 × roe) as a control for non-specific cytotoxicity. Nonspecific macrophage cytotoxicity was not observed in these cultures. An additional 2 to 4 wells which were infected but did not receive PEC served as virus controls. Antitumour activity was assessed in a morphological assay for cytotoxicity, as previously
Statistical methods. All titration (p.f.u.) data were expressed as log10 and the means, standard deviations and standard errors were determined. Student's two-tailed t-test was used to determine statistical significance of the data (Snedecor & Cochran, I967) .
Terminology. Peritoneal cells (PEC) are cells obtained from the peritoneal cavities of untreated (normal resident PEC) or treated mice. The term peritoneal macrophage is used for the adherent peritoneal cell population (remaining after vigorous washing of PEC monolayers at 2 h), recognizing that this population is not completely homogeneous. We have used the term 'activated macrophage' for those elicited macrophage populations which exhibit any functional changes in comparison with the resident macrophage (Bianco & Edelson, I978) .
RESULTS

Kinetics of antiviral activity of PEC during HS V-2 infection
Peritoneal cells from HSV-infected mice significantly reduced both HSV plaques and virus yield, while resident peritoneal cells had no effect (Table i) . Peritoneal cells from infected animals had no antiviral effect before day 3 p.i. ; peak activity occurred on days 3 and 4. Low levels of macrophage antiviral activity 7 days after HSV-2 infection were occasionally present, but no activity was observed at I4 days. The increase in p.f.u, observed I day after i.p. HSV-2 infection was apparently due to virus in the peritoneal cells (approx. 25 p.f.u./3 x lO 6 PEC); this local virus presence was not observed after the first day p.i.
Involvement of macrophages in antiviral activity
In order to define the cell type exhibiting antiviral activity, the relative effectiveness of adherent and non-adherent peritoneal cells was determined (Table 2) . Esterase-positive cells were reduced to I to 3 % in the non-adherent cell populations. The non-adherent cells, the majority of the PEC by number, had no effect on HSV-2 replication. In contrast, the adherent HSV-induced cells evidenced marked antiviral activity.
Non-specificity of the antiviral activity for species or virus
The antiviral effect was not specific for the species of host cell since mouse macrophages inhibited virus replication in xenogeneic Vero cells (Tables I and 2 ). In order to confirm the apparent lack of specificity for species, activity was determined using syngeneic mouse embryo fibroblasts (MEF) as the host cell. The activity on Vero cells and syngeneic MEF Day 3 4'3 38 5-5+P4 § < 3"0 Day 4 3"6 33 15"8 +_. ~ '9 § 3'7 * Vero cells were infected with HSV-2 and 3 x io 6 normal PEC or PEC from HSV-z-infected mice were adsorbed, non-adherent cells removed with washing and virus yields and p.f.u, were determined at 3 days.
t Differential count, Wright's stain. ~t P < 0"025. § P < O'OL Non-adherent 48"0 + 2"0 5"6 * Three x io e peritoneal cells were adsorbed to HSV-2-infected Vero cells for 2 h. The residual nonadherent cells were recovered and incubated with duplicate HSV-2-infected Vero cells. The yields of virus and p.f.u, were determined 3 days later. Approx. 28 to 30% of the total peritoneal cell population adhered within 2. h. t P < 0"05.
was comparable. In Vero cells, HSV-elicited PEC (3 × Ioe) reduced virus yield from 5"0 to 3"5 log10 and in MEF cells from 4"3 to 2-2 log10. The antiviral activity was also not specific for virus. HSV-elicited macrophages exhibited antiviral activity against VSV as well as HSV. VSV plaques were reduced from 32.5 + I .I to o.2 +0.2 p.f.u. (P < o'oo5), while HSV plaques were reduced from 48"5 + I.I to o (P < o.ooi) by incubation of virus-infected Vero cells with 2 × io 6 HSV-elicited PEC. Normal resident PEC had no statistically significant effect on either virus in these experiments.
Comparison of antiviral activity of PEC
Peritoneal cells obtained from HSV-2-infected mice were compared for macrophage characteristics and antiviral activity with peritoneal cells from mice treated with standard agents known to activate macrophages for various functions (Morahan et al. I977b; Bianco & Edelson, I978) . Both C. parvum and HSV infection slightly increased the PEC number and C. parvum also increased slightly the proportion of peritoneal macrophages (Table 3 )-However, the proportion of total cells adherent after 2 h in culture at 37 °C (30 to 4o %) was similar in all groups. Moreover, the proportion of esterase-positive or acridine orange-positive cells in the adherent populations was similar, ranging from 77 to
82%.
When Vero cells infected with HSV-2 were co-cultivated with PEC from HSV-, C. parvum- or thioglycollate-treated mice, HSV yield was reduced by 1"5 to 3"0 logx0 (Table 3 ). The antiviral activity was dose responsive. With total PEC at an initial concentration of Io o per well (approx. 0"5 to I.O macrophage per Vero cell), the antiviral effect was lost in most groups, while 2 x io ° or greater PEC consistently gave significant antiviral activity. Normal resident macrophages from untreated mice showed insignificant activity, even when tested at up to 5 x io e cells per well. In occasional experiments, normal peritoneal cells showed some antiviral activity, but always considerably less than the activated PEC; such activity was probably related to subclinical infection of mice, which is known to activate macrophages (Hibbs et al. 1972) . Peritoneal cells from mice inoculated only with GLB virus diluent also showed insignificant antiviral activity ( 1977b ). None of the PEC populations tested was cytotoxic for normal mouse embryo fibroblasts (MEF), even at a 20: I PEC:fibroblast ratio. The greatest ratio used in the antiviral experiments was about 6 PEC: i host cell.
As expected, C. parvum activated macrophages were selectively cytotoxic for the tumour cell targets (84~o cytotoxicity), while thioglycollate and normal resident peritoneal cells were relatively inactive (Table 4) . Peritoneal macrophages from HSV-2-infected mice exhibited cytotoxicity comparable to C. parvum PEC at the combined 2o:1 and IO:I PEC:target cell ratios. However, the HSV PEC were less active than the C. parvum PEC at lower macrophage to target cell ratios.
* Vero cells infected with HSV-2 were overlaid with I × to 6 to 3 × to e peritoneal cells for 2 h, the nonadherent cells removed with washing and virus yield measured 3 days later. The p.f.u./ml represent mean values from 4 to 8 experiments.
t Virus control for this experiment: 5'4. ~t P < o'oI as compared with HSV-2 yield in the control group. § P < 0"025 as compared with normal resident PEC. * PEC were tested in duplicate for cytotoxicity at two PEC:target cell ratios (2o: i and IO: I). In each experiment, cytotoxieity for Lewis lung carcinoma cells as compared to the control MEF target was assessed morphologically. Percent cytotoxicity was calculated from the combined four wells and expressed as positive if 50 to lOO % c.p.e, was observed. The percent cytotoxicity is the mean + s.e. from the indicated number of experiments. 3"5 + 0-5 3"4 + o.9 3"7 + o-6 HSV-2 3.7 + 1-o 3"6+0"5 3"6+0"9
C. parvum 3"5 +__0"5 3"5 ---0'5 3'6+0"9 * Undiluted supernatant fluids from 48 h macrophage cultures were'incubated at 37 °C for the times indicated with 5 x io 4 p.f.u, of HSV-2 and titre of residual virus was determined.
Lack of virus inhibition by some macrophage products
The antiviral activity could possibly be mediated by macrophage products which inhibit virus replication in host cells or by products (such as secreted lysosomal hydrolases) which destroy newly released virus extracellularly. Experiments were done to test the possibility that these effects could account for the antiviral activity.
To ascertain whether macrophage constituents might inhibit virus production in infected cells, lysates were obtained from 3 × Io6 frozen (-7o °C) and thawed macrophages and added to HSV-infected Vero cells directly after virus adsorption. With I ml of undiluted lysate per well, the yield of virus (log10 p.f.u./ml) in cultures with normal macrophage lysates was 6"3 as compared to 6.I in cultures with C. parvum macrophage lysates and 6.I in cultures with HSV macrophage lysates; none of these values was significantly different from the virus controls. In contrast to the lack of activity with macrophage lysates, the cultures with 3 × IO6 live macrophages (C. parvum-or HSV-elicited)exhibited the usual marked reduction in HSV yield.
Studies were also performed to determine whether active macrophages released products into the medium which could directly inactivate the virus. Normal, C. parvum and HSVelicited macrophages were plated at a concentration of 5 × Io e peritoneal cells per well in 24-well tissue culture plates, with I ml EMEM (2% FCS) per well. Supernatant fluids were collected after 48 h and centrifuged at 5oog for IO min to remove any contaminating unattached cells. The supematant fluids were incubated with 5 x io 4 p.f.u, of HSV-2. Supernatant fluids from the macrophage cultures did not themselves inactivate HSV within 6o min (Table 5 ). In addition, incubation times of up to 48 h in the mixture with macrophage supernatant fluids produced no loss in virus titre greater than that seen in the virus controls.
DISCUSSION
The present results demonstrate that macrophages with extrinsic antiviral activity appear after infection of mice with herpes simplex virus, showing peak activity at 3 to 4 days and declining by 7 to I4 days following infection. The response appeared to be an early event occurring before development of specific humoral or cell-mediated immunity, which does not occur until 6 to Jo days following systemic infection of BALB/c mice with HSV-2 (Morahan et al. I977a). Histopathological studies have also shown that mononuclear infiltrates are prominent in early virus foci in target organs following HSV infections (Johnson, I964; Zisman et al. I97o) . Macrophages may thus play a role in restricting virus replication before specific immune responses can be induced.
The antiviral activity reported here resided in the adherent peritoneal population, which consisted of at least 80 % esterase-positive cells that morphologically resembled macrophages/monocytes by light microscopy. Macrophages are also the effector ceils of extrinsic antiviral resistance by C. parvum-activated PEC. We have shown a loss of antiviral activity when C. parvurn PEC were treated in vitro with iron filings and the phagocytic cells removed with a magnet, correlated with a marked reduction of esterase-positive cells. Antiviral activity of C. parvum PEC was also reduced markedly when mice were treated with silica 2 h before harvesting PEC, a treatment which also substantially decreases the proportion of macrophages (Wright & Morahan, I976; McGeorge & Morahan, I978) . Our esterasepositive cells were also phagocytic for latex particles, in contrast to the esterase-positive, non-phagocytic adherent cell ('NPAC') subpopulation of antitumour cells recently described by Nathan et aL (r977). The adherence, morphological appearance, and esterase positivity of the cells also differentiates them from the NK or M cells which have been described to be cytotoxic for virus-infected cells in vitro but are non-adherent (Welch, I978) . The absence of antibody to HSV in our system suggests further that antibody-dependent, K-cell mediated cytoxicity was not operative in the present experiments (Handwerger & Koren, I976) . These data support the identification of the cells as macrophages.
The mechanisms of the extrinsic macrophage antiviral activity described here remain to be defined completely, but several aspects were delineated in the current experiments. Activity appeared to require viable macrophages and did not appear to involve direct inactivation of virus. Elicited macrophages are known to have increased synthetic and secretory capabilities (Bianco & Edelson, I978) and secretory products (such as neutral proteinases or prostaglandins) might be responsible for non-specific antiviral effects directly on viruses or virusinfected cells. Our results, however, indicate that direct inactivation of virus by supernatant materials, or antiviral activity mediated by macrophage lysates, does not occur. These data do not necessarily indicate that cell contact is required for antiviral activity; other macrophage products could be induced during culture of the macrophages. Experiments are in progress to determine whether activated macrophages show increased ability to adsorb virus or cause inhibition of host cell macromolecular synthesis, such that cells are rendered non-permissive for virus growth, and whether the activity is due to a soluble mediator. Our preliminary data indicate no enhanced virus adsorption by activated macrophages (Morse & Morahan, I979) ; Lopez & Dudas (I979) have recently reported similar findings.
Interferon is known to be produced in response to HSV, and can inhibit HSV replication (Lodmell & Notkins, I974) . However, unlike interferon-mediated inhibition, the macrophage antiviral activity described in this report was not species specific. HSV or C. parvum macrophages inhibited virus replication in xenogeneic Vero cells as well as in syngeneic mouse embryo fibroblasts. Mouse interferon produced by macrophages would not be effective on the Vero cells, which are of monkey origin; moreover, Vero cells do not produce interferon (Desmyter et aL I968 ).
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Certain agents, such as C. parvum, induce macrophages with tumour selective cytotoxicity as well as antiviral activity. However, cells which exhibit antiviral activity do not always exhibit antitumour activity (Morahan et al. I977b) . In the present experiments, HSVelicited macrophages appeared to share this characteristic of classically activated macrophages, tumour cell cytolytic capability. Schleupner et al. (1979) also found that infection of mice with murine CMV elicited macrophages which appeared to be activated by several criteria including tumour inhibition. The relationship between macrophage extrinsic antiviral effects and other activities of stimulated or activated macrophages is still speculative. Various infectious agents, including bacteria, protozoa (Nogueira et al. 1977 ) and helminths may activate macrophages (Wing et al. I979) . The antiviral activity of these macrophages has not been studied. It is also not known whether a particular subpopulation of macrophages may be the effectors of the antiviral activity, as has recently been reported to be the case with antitumour activity by Miller & Campbell (1978) , or whether that subpopulation might be distinct from those mediating other activities.
There have been limited studies on extrinsic antiviral resistance occurring during virus infection. We have previously demonstrated such activity after subclinical infection of mice with vaccinia virus, but the kinetics and relation to specific immune responses were not investigated (Morahan et al. I977b ) . Macrophages activated for bacterial resistance appeared during ectromelia virus infection of mice at a time when virus-specific immunity was present and macrophages were required for T-lymphocyte transfer of immunity, indirectly suggesting that macrophage antiviral activity occurred during that poxvirus infection (Blanden, 197I) . In our system, the macrophage antiviral activity occurred before specific immunity could develop. The activity was also not specific for virus, since HSV-elicited peritoneal cells were active against VSV, an unrelated RNA virus, as well as against HSV. This is similar to the non-specificity described in the vaccinia model (Morahan et aL 1977b) and in murine cytomegalovirus infection (Schleupner et al. I979), but different from the relatively virus-specific inhibitory activity expressed by adherent lymph node ceils from Sindbis virus-infected mice (McFarland & Johnson, I975) . The currently described activity also differs from the non-specific cytotoxicity for normal or virus-infected syngeneic or xenogeneic cells that occurs within 2 days after i.p. infection of mice with certain togaviruses, such as Semliki Forest virus. The effective cytotoxic peritoneal cell has recently been reported to be more closely related to a NK cell than to a macrophage (MacFarlan et al. 1977) . Macrophage-mediated cytotoxicity for virus-infected ceils has been reported to occur with or without the presence of virus-specific antibody against Sindbis or parainfluenza viruses (McFarland & Johnson, 1975; Stott et al. 1975 )-We have measured cytotoxicity in our system, using ~lCr-labelled Vero cells; preliminary results suggest that cytotoxicity is not a major component of the activity (Morse & Morahan, I979) .
The potential significance of the described activity in natural infection is intriguing. Brier et aL (197o) have described a chemotaxis-generating factor released by HSV-infected cells; such a factor could increase local accumulation of inflammatory cells. It is tempting to speculate that the macrophages so attracted might be activated by local factors and restrict HSV replication by expression of intrinsic or extrinsic antiviral activity. Macrophages probably inhibit virus replication through several mechanisms, the relative importance of each and its relationship to cell-and antibody-mediated defences, varying with the particular macrophage and virus system. We thank Keith Mahoney for assistance with the tumour cytotoxicity assays and Dr Anthony Segreti (Department of Biostatistics) for statistical consultation and assistance. This work was supported by research grants CA I6193 and CA 24686 from the National Cancer Institute, Grant IN-lo5C from the American Cancer Society and Training Grant
